Does the name Clay Siegall sound familiar to you? Have you ever heard of a person with this particular name? The Clay Siegall of this article may be one of the most important persons in cancer research. Why? Clay Siegall, M.D., has helped to revolutionize cancer research via drug development, scientific innovation and rigorous research. He has instilled these key features right into the business and great results have come forth ever since. He also has a heart of gold thanks to his philanthropic nature. The fight against cancer has been waging for decades and decades, but things have gotten much better.
Dr. Siegall is the CEO, the founder and the president for one of the nation’s premier oncology organization. This organization is Seattle Genetics, and it has become a worldwide leader in cancer research. Dr. Siegall, and his team of specialists use some of the most innovative technologies to study this deadly disease. As of now, the organization has up to 20 advanced drugs in its pipeline of success. Four of the twenty drugs could potentially be released within the next few years. Dr. Siegall uses his supreme knowledge to come-up with better solutions to fight this disease. The days of radical surgeries and amputation are far behind us thanks to the advancements in technology.
The FDA-approved drug, ADCETRIS, is the organization’s best-seller. This drug is known as an antibody-drug conjugate. By attaching itself to cancerous cells in the body, it will then go on to deliver its cocktails right into the cancerous cells. One of the best things about this drug is that it won’t leave the patient with sickening effects. Dr. Clay Siegall’s greatness in cancer research can’t be disputed because he has over 30 years of experience, he currently holds at least 15 medical patents, and he has written a plethora of cancer-related publications.